iShares MSCI EAFE International Index Fund
BlackRock Index Funds, Inc. · Series S000003116
data updated 2026-08-10
Fund profile
As filed in the prospectus · 2026 Q2
The investment objective of iShares MSCI EAFE International Index Fund ( MSCI EAFE International Index Fund or the Fund ), a series of BlackRock Index Funds, Inc. (the Corporation ), is to match the performance of the MSCI EAFE Index (Europe, Australasia, Far East) (the MSCI EAFE Index or the Underlying Index ) in U.S. dollars with net dividends as closely as possible before the deduction of Fund expenses.
The fund employs a passive strategy to track the MSCI EAFE Index, investing in a statistically selected sample of equity securities across all countries represented in the index rather than holding every constituent. Because the fund samples the index rather than replicating it exactly, its performance may diverge from the index.
| Share class | Expense ratio |
|---|---|
| C000008447 | 0.34% |
| C000008448 | 0.09% |
| C000099168 | 0.04% |
| C000201956 | 0.34% |
| C000244427 | 0.03% |
Portfolio turnover 8.00% · as of 2026 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q1
| Stocks | 98.96% |
| Cash & short-term | 0.37% |
| Derivatives | -0.00% |
The outer band is exposure held short — written against the portfolio rather than part of it, which is why it sits outside the ring and why the two are never netted into one figure.
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: Roche Holding AG, Reckitt Benckiser Group PLC, SUNB, Tower Semiconductor Ltd, Ibiden Co Ltd, BAWAG Group AG, Shimizu Corp, QIAGEN NV
Largest exited: Roche Holding AG, Reckitt Benckiser Group PLC, Ashtead Group PLC, CyberArk Software Ltd, Hang Seng Bank Ltd, QIAGEN NV, JDE Peet's NV, DCC PLC
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Feb 2026
Mar 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
This fund changed legal form during the period shown. The history above is continuous — it spans both eras, and the change is not a gap in reporting.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Value | Shares |
|---|---|---|---|---|
| — | ASML Holding NV | 2.50% | $322.03M | 242.2K |
| — | AstraZeneca PLC | 1.47% | $189.21M | 967.6K |
| — | Novartis AG | 1.41% | $182.07M | 1.2M |
| — | HSBC Holdings PLC | 1.37% | $175.98M | 10.7M |
| — | Roche Holding AG | 1.36% | $174.94M | 438.3K |
| — | Shell PLC | 1.28% | $164.69M | 3.6M |
| — | Nestle SA | 1.23% | $157.68M | 1.6M |
| — | Toyota Motor Corp | 0.95% | $122.91M | 5.9M |
| — | Commonwealth Bank of Australia | 0.95% | $122.27M | 1.0M |
| — | Mitsubishi UFJ Financial Group Inc | 0.93% | $119.12M | 7.0M |
Top 10 positions are 13.44% of net assets, top 25 24.47%, across 691 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free